The Menopause Consortium’s Post

Menopause Hormone Therapy (MHT) has long been a solution for managing these symptoms. But what about postmenopausal women who have experienced a myocardial infarction (MI)? The latest factsheet from the British Menopause Society sheds light on this critical topic. Here are some key takeaways: 1) Beneficial Effects on Arterial Health: Oestrogen, a key component of MHT, offers substantial benefits to arterial health. It improves vascular function and reduces atheroma formation, potentially lowering the risk of coronary events. 2) Considerations for Arterial Disease**: For women with existing arterial disease, the choice of MHT regimen becomes crucial. Studies indicate that lower doses of oestrogen, preferably administered non-orally, along with non- androgenic progestogens, are associated with favourable outcomes. 3) Post-MI Management: Contrary to common perception, current MHT users at the time of an MI may have lower mortality rates. The decision to continue or initiate MHT post-MI should be made with caution, considering factors such as age, hormone type, dose, route of administration, and co-administration of statins. 4) Practice Recommendations: The factsheet emphasises the importance of personalised MHT regimens tailored to individual patient profiles. It suggests careful monitoring and collaboration with specialist menopause clinics for optimal management. This comprehensive resource, authored by distinguished experts, provides invaluable insights for healthcare professionals navigating the complex landscape of MHT post-MI. For more details, refer to the full factsheet from the British Menopause Society. Stay informed, stay proactive! https://lnkd.in/ev7Mi6_G #HRT #MenopauseManagement #CardiovascularHealth #MedicalResearch

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics